Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Multiple Sclerosis and Related Disorders|May 9, 2022
Differential antibody response to COVID-19 vaccines across immunomodulatory therapies for multiple sclerosisSammita Satyanarayan, Neha Safi, Tali Sorets, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 16, 2020
Depression and cognitive function in early multiple sclerosis: Multitasking is more sensitive than traditional assessmentsLisa Glukhovsky, Daniel Kurz, Rachel Brandstadter, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 23, 2020
Hippocampal volume is more related to patient-reported memory than objective memory performance in early multiple sclerosisLisa Glukhovsky, Rachel Brandstadter, Victoria M Leavitt, et al.
Multiple Sclerosis and Related Disorders|June 2, 2021
Dietary factors and MRI metrics in early Multiple SclerosisI B Katz Sand, Kathryn C Fitzgerald, Yian Gu, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 20, 2019
Word-finding difficulty is a prevalent disease-related deficit in early multiple sclerosisRachel Brandstadter, Michelle Fabian, Victoria M Leavitt, et al.
Annals of Clinical and Translational Neurology|May 5, 2021
Sleep disturbance and memory dysfunction in early multiple sclerosisJames F Sumowski, Sam Horng, Rachel Brandstadter, et al.
Multiple Sclerosis and Related Disorders|September 3, 2021
Myelin oligodendrocyte glycoprotein (MOG) antibody-mediated disease: The difficulty of predicting relapsesSamantha E Epstein, Seth Levin, Kaho Onomichi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 25, 2019
Dissociable cognitive patterns related to depression and anxiety in multiple sclerosisVictoria M Leavitt, Rachel Brandstadter, Michelle Fabian, et al.
Multiple Sclerosis and Related Disorders|January 11, 2023
Evaluation of immunological responses to third COVID-19 vaccine among people treated with sphingosine receptor-1 modulators and anti-CD20 therapyIlana Katz Sand, Sacha Gnjatic, Florian Krammer, et al.
Medrxiv : the Preprint Server for Health Sciences|June 23, 2022
Evaluation of immunological responses to third COVID-19 vaccine among people treated with sphingosine receptor-1 modulators and anti-CD20 therapyIlana Katz Sand, Sacha Gnjatic, Florian Krammer, et al.
Pageof 3